Top Stories
-
Columbia physicians explain why long COVID is still a “thing” and what we need to know to better identify and treat patients with the syndrome.
Topic
-
An infectious diseases expert explains why the new boosters target the omicron variant and who should get one.
Topic
-
The coming COVID boosters aren't the only vaccines adults should consider. Now's a good time for people over 18 to make sure they're up to date with flu, tetanus, and other routine vaccines.
Topic
-
More than 90% of Americans have been immunized against polio, but the news is still unsettling and has many wondering if they’re at risk of becoming infected or even paralyzed.
Topic
Latest News
- October 28, 2021
Columbia clinical microbiologist Gregory Berry, PhD, explains what rapid at-home tests can—and cannot—do to help keep us and those around us safe from COVID.
Topic
- October 12, 2021
The new Pandemic Response Institute draws heavily on ICAP’s strength in building partnerships and will help New York City equitably detect, respond to, and recover from major health emergencies.
Topic
- October 7, 2021
After infection with the COVID virus, where does the immune system store the memory? A new study finds memory cells take up residence in the lung to protect against reinfection.
Topic
- September 30, 2021
With an award from New York City Economic Development Corporation, Columbia—through its Mailman School of Public Health—and a consortium will launch NYC’s first Pandemic Response Institute.
Topic
- September 29, 2021
Kidney transplant recipients and those waiting for a transplant face a high risk of dying from COVID, with patients from racial and ethnic minorities at greater risk.
Topic
- September 15, 2021
City neighborhoods with the highest COVID vaccination rates had lower historical COVID death rates, showing that lifesaving vaccines have been slow to reach the pandemic's hardest-hit areas.
Topic
- September 13, 2021
Wafaa El-Sadr, who helps lead the University’s COVID response, offers her tips for commuting safely amid COVID-19 and the delta variant.
Topic
- August 31, 2021
A new antimalarial drug candidate has the potential to be a single-dose treatment, according to a new report from researchers at Columbia University.
- August 27, 2021
About 100 million Americans were infected with SARS-CoV-2 in 2020, but only 22% of infections were documented, a study from researchers at the Mailman School of Public Health has found.
Topic
- August 23, 2021
Melissa Stockwell, Columbia pediatrician (and mom), addresses questions about COVID-19, the Delta variant, and the return to in-person schooling.
Topic
